| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514060000 | Starch or derivative | 27 |
| 20080207562 | Conjugates of Hydroxyalkyl Starch and Active Substance, Prepared by Chemical Ligation Via Thiazolidine - The present invention relates to a method for preparing conjugates of an active substance and hydroxyalkyl starch and to conjugates of an active substance and hydroxyalkyl starch, preferably hydroxyethyl starch, wherein the conjugates are prepared by covalently linking the hydroxyalkyl starch and the active substance by a chemical residue having a structure according to formula (I) | 08-28-2008 |
| 20080214498 | Solution for peritoneal dialysis - The present invention provides a solution for peritoneal dialysis, consisting of at least two single solutions which are combined after a heat sterilization and are administered to a patient, the first single solution containing an osmotic and the second single solution containing a buffer, and one of these single solutions or another single solution containing electrolyte salts. Glucose-like degradation and hydrolysis is avoided during sterilization and storage, while maintenance of a neutral mixture pH is achieved by the osmotic comprising a glucose polymer and/or glucose polymer derivative, and the pH of the first single solution being between 3.5 and 5.0. The present invention further discloses a twin-chambered pouch consisting of a plastic pouch with at least one first chamber and a second chamber, the first single solution being included in the first chamber and the second single solution being included in the second chamber. | 09-04-2008 |
| 20090062233 | Modified starch material of biocompatible hemostasis - A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal. | 03-05-2009 |
| 20090118231 | Pectin-modified resistant starch, a composition containing the same and method for preparing resistant starch - This invention relates to a pectin-modified resistant starch prepared by cross-linking starch with pectin by pectinesterase reaction. Such resistant starch is low amylase digestible and thus is useful in food products, including nutritional supplements, to reduce calorie content and increase fiber content. This invention also relates to a composition containing the resistant starch and a process for the preparation of the same. | 05-07-2009 |
| 20090275531 | Method for producing starch networks and initial products - The invention relates to a method for producing starch networks. The method may include preparing a basic starch and preparing a networking starch. The method may further include manufacturing an initial product including the basic starch and the networking starch, and processing the initial product to yield the starch networks, such that the starch networks are at least partially heterocrystallized. | 11-05-2009 |
| 20100099648 | NATURAL EQUIVALENT OF CHEMICALLY MODIFIED STARCH - The present invention relates to a composition comprising citrus fruit fiber having a water binding capacity of from 8 to 25 (w/w) and native starch selected from the group consisting of corn starch, rice flour, sorghum starch, tapioca starch and mixture thereof. | 04-22-2010 |
| 20100120713 | COMPOSITIONS CONTAINING BETA-CAROTENE - The present invention relates to compositions for the enrichment, fortification and/or coloration of food, beverages, animal feed, cosmetics or pharmaceutical compositions comprising at least one modified starch, β-carotene and optionally at least an adjuvant and/or an excipient, wherein a mixture of the composition with water has a color hue in the range of 48 to 60. | 05-13-2010 |
| 20100168061 | METHOD FOR PREPARING ENZYMATICALLY HIGHLY BRANCHED-AMYLOSE AND AMYLOPECTIN CLUSTER - The present invention relates to a method for preparing enzymatically highly branched-amylose and amylopectin cluster. Alpha-glucanotransferase or branching enzyme hydrolyzes the linkage of the segment between amylopectin clusters in starch, producing amylopectin cluster, and simultaneously branching enzyme attaches the branched side-chain to amylose, producing branched amylose, and subsequently treating the amylopectin cluster or branched amylose with maltogenic amylase for cleaving long side chain into short side chain and for transferring glucose to the side chain, generating highly branched amylopectin cluster, highly branched amylose or branched oligosaccharide from starch effectively. | 07-01-2010 |
| 20100298266 | HYDROXYETHYLSTARCH - Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases. | 11-25-2010 |
| 20100305064 | TOPICAL SKIN CARE COMPOSITIONS - The present invention relates to an oil-in-water emulsion. The emulsion comprises a starch and a quaternary ammonium salt. The concentration of the quaternary ammonium salt is greater than about 0.5 percent by weight of the composition, the concentration of starch is greater than about 3 percent by weight of the composition, and the combined concentration of the quaternary ammonium salt plus the starch is greater than about 4 percent by weight of the composition. Methods of treating the skin are provided. | 12-02-2010 |
| 20110212916 | Method and means for improving bowel health - A method and composition for improving one or more indicators of bowel health or metabolic health in a mammalian animal. This comprises the delivering to the gastrointestinal tract of the animal an effective amount of an altered wheat starch in the form of or derived from the grain of a wheat plant. The proportion of amylose in the starch of the grain is at least 30% and/or the grain comprises a reduced level of SBEIIa enzyme activity and/or protein relative to wild-type grain. | 09-01-2011 |
| 20110237542 | COMPOSITION FOR PREVENTING ADHESION - The present invention relates to a composition for preventing tissue adhesion which comprising a bio-compatible hyaluronic acid and a polymer compound. More specifically, the invention is a composition containing hyaluronic acid which has not been modified by a chemical crosslinking or other chemical modification a method for preparing the same, and a composition for adhesion prevention with superior efficacy. | 09-29-2011 |
| 20120129805 | BARLEY AND USES THEREOF - The invention provides barley gain comprising a reduced level or activity of starch synthase IIa protein and a starch content of at least 41% (w/w) and methods of producing, identifying and using same. The grain may comprise an amylase content of at least 50%, a β-glucan content of 5-9% (w/w) or greater than 9% (w/w), and/or a fructan content of 3-11% (w/w). The fructan may comprise a degree of polymerization from about 3 to about 12. For example, the plant and grain comprises a sex6-292 allele and/or an amo1 mutation. A food or beverage product, and methods of producing a food or beverage product, comprising obtaining or producing the subject grain and processing the grain to produce the product. Also contemplated are methods of improving one or more indicators of health in a mammal comprising administering a composition comprising the subject barley grain or a product comprising same. | 05-24-2012 |
| 20120245123 | METHODS FOR IMPROVING BONE HEALTH IN INFANTS USING PREBIOTICS - Disclosed are methods for improving bone health, strength and formation in an infant who may be susceptible to developing bone health issues from conception through adolescence. The methods include administration of a nutritional formulation including a prebiotic to a woman during pregnancy and optionally during lactation and breastfeeding of an infant. | 09-27-2012 |
| 20120295873 | BRANCHED SOLUBLE GLUCOSE POLYMERS FOR PERITONEAL DIALYSIS - The invention relates to branched soluble glucose polymers made of starch having an amylose content of at least 30 wt %, preferably 35 wt % to 80 wt %, having a glycosidic linkage α-1,6 content of 7% to 10%, preferably 8% to 9%, and a MW of 50,000 to 150,000 daltons, characterized in that the polymers are resistant to pancreatic alpha amylase, expressed according to a test “B” for a reducing sugar content of 25% to 35%, and a MW of released products of 6,000 to 12,000 daltons. | 11-22-2012 |
| 20130005685 | STARCH DERIVATIVE MIXTURES - The invention relates to a compound, comprising
| 01-03-2013 |
| 20130184237 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES - The present invention relates to nitric oxide delivering hydroxyalkyl starch derivatives, methods of preparing the same, and specific uses of these hydroxyalkyl starch derivatives. | 07-18-2013 |
| 20130196949 | Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates - The present invention relates to hydroxyalkyl starch or a pharmaceutical preparation thereof for the treatment of cancer, tumor or tumor associated diseases, especially by effectively reducing tumor growth rate and inhibiting tumor growth and wherein the hydroxyalkyl starch has a mean molecular weight (MW) above 20 and below 1300 kDa and a molar substitution (MS) in the range of from 0.1 to 1.5, wherein the alkylation may be an ethylation, propylation or butylation or mixes thereof; and wherein the alkyl may be further substituted. | 08-01-2013 |
| 20140073602 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES - The present invention relates to nitric oxide delivering hydroxyalkyl starch derivatives, methods of preparing the same, and specific uses of these hydroxyalkyl starch derivatives. | 03-13-2014 |
| 20140179629 | SLOWLY DIGESTING STARCH AND FERMENTABLE FIBER - Compositions which provide slowly digestible starch and a source of fermentable dietary fiber. Microparticles in which starch is entrapped in a crosslinked matrix to provide dietary benefit. Such microparticles are used to deliver glucose to targeted regions in the small intestine for beneficial physiological effects, and fermentable dietary fiber to the colon to improve colon health and to treat diseases of the colon. Microparticles can be employed to selectively deliver fermentable dietary fiber to targeted portions of the colon. | 06-26-2014 |
| 20150296850 | USE OF POLYSACCHARIDES FOR THE INTESTINAL WELL-BEING OF NURSING INFANTS AND/OR INFANTS - The use of a polysaccharide in a method for improving the flora of the colon of nursing infants and/or infants, thus treating or preventing colic and enterocolitis and therefore improving and/or generally stimulating the intestinal well-being of nursing infants and/or infants. A food composition for feeding nursing infants and/or infants, including at least one polysaccharide for treating or preventing colic and enterocolitis and improving and/or stimulating the intestinal well-being of nursing infants and/or infants. The polysaccharide used is a branched maltodextrin, preferably with a molecular mass of between 400 and 4500. | 10-22-2015 |
| 20150329648 | INTESTINAL ENVIRONMENT-IMPROVING AGENT - An intestinal environment-improving agent containing, as an effective component, a starch with a high resistant starch content that satisfies the following conditions (a), (b), (c), and (d):
| 11-19-2015 |
| 20160008392 | AGENT FOR LIFESTYLE-RELATED DISEASE AND ORAL COMPOSITION COMPRISING SAME | 01-14-2016 |
| 20160046732 | ASEPTIC POLYMERIC COMPOSITIONS AND METHODS OF USING THE SAME - Aseptic polymers, methods for their preparation, and uses are provided, which include, for example, as disinfectants and other uses. | 02-18-2016 |
| 20160082036 | HYDROXYALKYL STARCH FOR THE TREATMENT OF CANCERS BY REDUCTION OF TUMOR GROWTH RATES - The present invention relates to hydroxyalkyl starch or a pharmaceutical preparation thereof for the treatment of cancer, tumor or tumor associated diseases, especially by effectively reducing tumor growth rate and inhibiting tumor growth and wherein the hydroxyalkyl starch has a mean molecular weight (MW) above 20 and below 1300 kDa and a molar substitution (MS) in the range of from 0.1 to 1.5, wherein the alkylation may be an ethylation, propylation or butylation or mixes thereof; and wherein the alkyl may be further substituted. | 03-24-2016 |
| 20160175340 | POLYSACCHARIDE FOR USE IN PREVENTING METASTASIS FORMATION AND/OR RELAPSE | 06-23-2016 |
| 20160175341 | HYDROXYALKYL STARCH FOR THE TREATMENT OF HEMATOLOGICAL NEOPLASMS | 06-23-2016 |
